Intentional weight loss of 5%, 10%, and 15% led to the discontinuation of at least one antihypertensive medication in 3%, 39%, and 39% of overweight and obese patients, respectively.
Cohort (n=100)
Yes
Does a weight loss intervention reduce the need for antihypertensive medications in overweight and obese patients?
Intentional weight loss in overweight and obese patients is associated with significant dose reductions or discontinuations of antihypertensive medications.
BACKGROUND: Though it is well known that weight loss tends to decrease blood pressure, the quantitative association between the magnitude of weight loss and the effect on the need for antihypertensive medications is not well studied. We analyzed this association among overweight and obese attendees at two outpatient weight management centers. METHODS: Case records of patients with a body mass index >25 at baseline were analyzed. The weight loss intervention consisted of a calorie-restricted diet (~1,000 kcal/day deficit), a behavior modification plan, and a plan for increasing physical activity. RESULTS: The study cohort consisted of 100 participants, and the mean follow-up period was 15 ± 3.5 months. Significant weight loss (12.2 ± 3.4 kg) and systolic/diastolic blood pressure reductions (9.1/6.3 mm Hg) were observed by study exit. For 5, 10, and 15% weight loss, respectively, 3, 39, and 39% of the patients achieved at least 1 discontinuation of any antihypertensive medication, and 8, 42, and 21 dose reductions were achieved. Dose reductions or discontinuations occurred in all classes of antihypertensive medications with similar magnitudes of weight loss. CONCLUSIONS: Intentional weight loss can potentially result in dose reductions/discontinuations of antihypertensive medications. Our results should be validated with data from larger randomized controlled studies and may help to inform the conduct of a systematic review of prior randomized controlled trials that contain data on medication changes accompanying weight loss.
Shantha et al. (Tue,) conducted a cohort in Overweight and obesity (n=100). Intentional weight loss was evaluated on Discontinuation or dose reduction of antihypertensive medications. Intentional weight loss of 5%, 10%, and 15% led to the discontinuation of at least one antihypertensive medication in 3%, 39%, and 39% of overweight and obese patients, respectively.